Moleculin Biotech
MBRX
MBRX
31 hedge funds and large institutions have $10.9M invested in Moleculin Biotech in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.19% more ownership
Funds ownership: 0.5% → 0.7% (+0.19%)
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.12M | |
| 2 | +$230K | |
| 3 | +$220K | |
| 4 |
SCM
Sio Capital Management
New York
|
+$154K |
| 5 |
BlackRock
New York
|
+$139K |
Top Sellers
| 1 | -$136K | |
| 2 | -$118K | |
| 3 | -$111K | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$109K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$50K |